isis 14803
Nucleic acidexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started May 6, 2002 (NCT00035945)
Timeline
Indications
Studied for
Mechanism of action
- Hepatitis C virusINHIBITOR
Hepatitis C virus inhibitor
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Also known as
- isis 14803
- isis 14803
- isis 14803
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00062816 | Phase 1/Phase 2 (Phase 2) | May 1, 2004 | Ionis Pharmaceuticals, Inc. |
| NCT00035945 | Phase 2 | May 6, 2002 | Elan Pharmaceuticals, Ionis Pharmaceuticals, Inc. |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Ionis Pharmaceuticals, Inc. | For profit | 2 | 2 | 1 | 2002 |
| Elan Pharmaceuticals | For profit | 1 | 0 | 1 | 2002 |
2 organizations
Page 1 / 1